Skip to main content
. 2013 Apr 14;19(14):2242–2248. doi: 10.3748/wjg.v19.i14.2242

Table 3.

Adverse effects among the 262 patients n (%)

Adverse effect Grade 1 Grade 2 Grade 3 Grade 4
Nausea/vomiting 160 (61.1) 48 (18.3) - (-) - (-)
General fatigue 28 (10.7) 17 (6.5) 1 (0.4) - (-)
Fever 168 (64.1) 27 (10.3) - (-) - (-)
Abdominal pain 121 (46.1) 54 (20.6) - (-) - (-)
Leucopenia 13 (4.9) 2 (0.7) - (-) - (-)
Thrombocytopenia 16 (6.1) 2 (0.7) - (-) - (-)
AST/ALT 154 (58.8) 46 (17.6) - (-) - (-)
Liver abscess - (-) 2 (0.7) 2 (0.7) - (-)
Hepatic/Renal failure - (-) - (-) 1 (0.4) - (-)

Data are expressed as number of patients with percentages in parentheses. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.